See today's BioWorld Science
To read the full story, subscribe or sign in.
Neurology/Psychiatric

Sangamo and Voyager enter license agreement to combine TRACER capsid with ZF-TRs to treat prion disease

June 30, 2023
Sangamo Therapeutics Inc. and Voyager Therapeutics Inc. have entered into a definitive license agreement for a potential treatment for prion disease.
BioWorld Science License Neurology/psychiatric